Inactive Instrument

Insiders Dicerna Pharmaceuticals, Inc.

Equities

DRNA

US2530311081

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Insider Sell: Dicerna Pharmaceuticals	21-11-22	MT
Dicerna Pharmaceuticals : Names Rob Ciappenelli Chief Strategy Officer	21-09-22	MT
Dicerna Pharmaceuticals, Inc. Announces Executive Appointments	21-09-22	CI
Insider Sell: Dicerna Pharmaceuticals	21-09-21	MT
Insider Trends: Insider Buying Continued with Purchase of Dicerna Pharmaceuticals Stock	21-08-10	MT
Insider Trends: Dicerna Pharmaceuticals Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	21-06-17	MT
Insider Trends: Dicerna Pharmaceuticals Insider Continues 90-Day Selling Trend	21-04-20	MT
Insider Trends: Dicerna Pharmaceuticals Insider Extends 90-Day Selling Trend	21-02-08	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Dicerna Pharmaceuticals	21-01-13	MT
Insider Trends: Dicerna Pharmaceuticals Insider Continues 90-Day Selling Trend	21-01-13	MT
Insider Trends: Insider at Dicerna Pharmaceuticals Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected	21-01-12	MT
Dicerna Pharmaceuticals : Announces Novo Nordisk's Nomination of First Candidate for Development under RNAi Discovery and Development Agreement and Additional Milestone Achievement	21-01-06	AQ
Dicerna Pharmaceuticals : Announces Novo Nordisk’s Nomination of First Candidate for Development Under RNAi Discovery and Development Agreement and Additional Milestone Achievement	21-01-05	BU
Dicerna Pharmaceuticals, Inc. Announces Novo Nordisk A/S Nomination of First Candidate	21-01-05	CI
Insider Trends: Insider Adds to Selling Trend at Dicerna Pharmaceuticals	20-12-14	MT
Dicerna Pharmaceuticals, Inc. Appoints Ling Zeng as Chief Legal Officer and Secretary	20-09-16	CI
Dicerna Pharmaceuticals, Inc. Appoints Shreeram Aradhye as Executive Vice President and Chief Medical Officer, Effective Sept. 8, 2020	20-08-05	CI
Dicerna Pharmaceuticals, Inc. Appoints Douglas Pagán as Chief Financial Officer and Member of Executive Leadership Team, Effective May 26, 2020	20-05-07	CI
Dicerna Pharmaceuticals, Inc. Announces Resignation of Ralf Rosskamp as Chief Medical Office	20-04-20	CI
Dicerna Pharmaceuticals, Inc. Appoints Stephen Doberstein as Independent Director	20-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Dicerna Pharmaceuticals, Inc.

Equities

DRNA

US2530311081

Insiders

Filters